Effectiveness and Cost-utility Analysis of Spinal Cord Stimulation for Chronic Intractable Pain in Thailand
- Conditions
- Patients undergoing SCS implants due to intractable pain at Siriraj Hospitalspinal cord stimulationeffectivenessquality-adjusted life yearincremental cost-utility ratioscost-utility analysiswillingness to payThailand
- Registration Number
- TCTR20210923001
- Lead Sponsor
- Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
CMM group
1) The patients were more than 7 years old
2) The patients suffered from chronic intractable pain from FBSS, PVD or neuropathic pain
3) The patients reported no satisfactory response to previous treatment defined by a pain score (numeric rating scale or NRS) of at least 5 out of 10 for at least 2 years, despite physical therapy, appropriate regimen of pain medication (gabapentin dose of more than 900 mg/day or pregabalin more than 150 mg/day and two or more other pain medications), other pain interventions or surgery.
SCS+CMM group
Any patients who underwent a successful SCS trial and subsequent implantation.
1. Refusal to participate in the study
2. Pain due to cancer 3. Difficulty of communication or poor literacy of Thai language
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cost-utility Post-treatment (3 years time points) incremental cost-utility ratio
- Secondary Outcome Measures
Name Time Method Pain score Post-treatment (1-6 months time points) Numeric rating pain score range: 0-10,Overall pain-related interference Post-treatment (1-6 months time points) Brief Pain Inventory questionnaire (range: 0-70),Utility Post-treatment (1-6 months time points) EQ-5D-5L health questionnaires21(Thai version)